Anzeige
Mehr »
Freitag, 07.08.2026 - Börsentäglich über 12.000 News
Schwere Seltene Erden: Entsteht hier die nächste Milliardenstory?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A412T6 | ISIN: SE0023837091 | Ticker-Symbol: R0A
Frankfurt
07.08.26 | 09:10
4,365 Euro
-0,91 % -0,040
1-Jahres-Chart
QUALISYS HOLDING AB Chart 1 Jahr
5-Tage-Chart
QUALISYS HOLDING AB 5-Tage-Chart
GlobeNewswire (Europe)
308 Leser
Artikel bewerten:
(1)

Qualisys Holding AB: Qualisys Launches OnTraq, Redefining Functional Assessment in Elite Sport

Qualisys, a global leader in Motion Capture technology, today announced the official launch of OnTraq, an end-to-end markerless analysis system designed to redefine how elite sports organizations conduct athlete baseline testing.

Following a six-month deployment across professional teams, universities, and high-performance centers, OnTraq is now available as a subscription-based platform for broader rollout across elite sports organizations. The system delivers high-quality functional assessments at scale and supports ongoing performance monitoring - making assessments faster and more efficient for both athletes and coaching staff.

"OnTraq will bring significant value for elite sports teams," said Ingemar Pettersson, CEO of Qualisys. "We see the global sports industry growing, and more importantly, expanding its adoption in technology. Teams are actively seeking more efficient and integrated ways to monitor athletes, and OnTraq meets that demand directly."
For years, elite sports organizations have faced a familiar compromise: research-grade motion capture systems offer accuracy but require extensive setup and specialist operation, while faster tools sacrifice consistency and data quality. OnTraq removes this tradeoff. Powered by Qualisys' proprietary technology, teams can assess a full roster of 20 athletes in approximately 30 minutes, producing consistent, repeatable results without disrupting training schedules.

The streamlined workflow provides athletes with objective, individualized insights while giving coaches and performance staff immediate access to reliable data to support training design, planning and adjustment of training, and return-to-play decisions.

"OnTraq is the result of years of collaboration between product experts and core technology engineering," said Magnus Berlander, CTO of Qualisys. "We built it for elite sports teams, where staff need accurate, repeatable insights in minimal time. OnTraq delivers the precision Qualisys is known for in an intuitive system, giving coaches immediate, easy-to-use access to actionable data."

During the six-month beta period, OnTraq consistently exceeded expectations in high-volume settings. Individual sites completed hundreds of assessments within a single week without requiring technical support, highlighting both the robustness of the system and its ease of use in real-world performance environments.

"Early feedback fundamentally shaped the product," said Oskar Lindh, Product Manager for OnTraq. "What to measure, how results should be presented, and how quickly staff need to act on the data-all of that came directly from performance teams. OnTraq reflects how elite staff actually work."

OnTraq features patent-pending automatic movement detection technology, positioning it to reshape routine functional assessments across elite sport. The system has already attracted interest from clubs competing at the highest levels in Europe and North America, including the Premier League, Serie A, NFL, and MLS.

OnTraq is available immediately as a subscription-based service with Bronze, Silver, and Gold tiers.

Read more and visit Ontraq

For more information, please contact:

Ingemar Pettersson, CEO Qualisys
Phone: +46 (0) 31 336 94 18

About Qualisys Holding AB (publ)
Qualisys is a leading provider of motion capture technology and has a long history of supplying research, engineering, entertainment, and sports facilities with high-end camera systems and expertise in capturing and analyzing movements. Qualisys offers a wide range of products and services with its headquarter in Gothenburg, Sweden, and operations in Chicago, Singapore, Shanghai and Delhi. Qualisys is certified according to ISO 9001:2015, the clinical products are compliant with Medical Device Directive 93/42/EEC and have FDA clearance (K171547).

Qualisys is listed on Nasdaq First North Premier Growth Market. The company's Certified Adviser is Svensk Kapitalmarknadsgranskning AB.

Image Attachments
OnTraq By Qualisys Yellow Oval Horiz Rgb

© 2026 GlobeNewswire (Europe)
Achtung, Korrektur!
Die Börsen laufen heiß. Trotz geopolitischer Krisen und steigender Zinsen klettern viele Indizes weiter Richtung Allzeithoch. Doch unter der Oberfläche zeigen sich erste Risse: Der Abverkauf bei Halbleiter-, KI- und Space-Aktien macht deutlich, wie schnell sich die Stimmung drehen kann.

Besonders gefährlich ist die aktuelle Gemengelage aus schwacher Saisonalität, dünner Liquidität in den Sommermonaten und historisch hohen Bewertungen. Selbst vermeintlich sichere Blue Chips sind inzwischen teuer bewertet und damit anfällig für Korrekturen. Gleichzeitig liefern technische Indikatoren erste Warnsignale. So werden viele Rekordstände nicht mehr bestätigt.

Für Anleger steigen die Risiken spürbar. Wer jetzt nicht genauer hinschaut, läuft Gefahr, auf dem falschen Fuß erwischt zu werden.

In unserem aktuellen Spezialreport zeigen wir fünf Aktien, bei denen die Abwärtsrisiken besonders hoch sind – und wo sich Gewinnmitnahmen oder sogar Short-Strategien anbieten könnten.

Jetzt den kostenlosen Report sichern – bevor die Korrektur Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.